Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

The fabrication of three-dimensional plasmonic chiral structures by dynamic shadowing growth.

Larsen GK, He Y, Ingram W, LaPaquette ET, Wang J, Zhao Y.

Nanoscale. 2014 Jun 30. [Epub ahead of print]

PMID:
24975016
[PubMed - as supplied by publisher]
2.

Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma.

Noriega V, Kaur H, Devereux S, Byrne J, Marcus R, Haynes A, Yallop D, McMillan A, Ingram W, Khan A, Kenyon M, Potter V, Russell N, Mufti GJ, Pagliuca A.

Leuk Res. 2014 Jul;38(7):737-43. doi: 10.1016/j.leukres.2014.03.005. Epub 2014 Mar 18.

PMID:
24787231
[PubMed - in process]
3.

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.

Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C, Castel D, Grasso CS, Vinci M, Carvalho D, Carcaboso AM, de Torres C, Cruz O, Mora J, Entz-Werle N, Ingram WJ, Monje M, Hargrave D, Bullock AN, Puget S, Yip S, Jones C, Grill J.

Nat Genet. 2014 May;46(5):457-61. doi: 10.1038/ng.2925. Epub 2014 Apr 6.

PMID:
24705252
[PubMed - indexed for MEDLINE]
4.

VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).

Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

JAMA Ophthalmol. 2014 May;132(5):521-7.

PMID:
24652518
[PubMed - indexed for MEDLINE]
5.

Tunable three-dimensional helically stacked plasmonic layers on nanosphere monolayers.

He Y, Larsen GK, Ingram W, Zhao Y.

Nano Lett. 2014 Apr 9;14(4):1976-81. doi: 10.1021/nl404823z. Epub 2014 Mar 27.

PMID:
24646023
[PubMed - in process]
6.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

PMID:
24450891
[PubMed - indexed for MEDLINE]
7.

Hidden chirality in superficially racemic patchy silver films.

Larsen GK, He Y, Ingram W, Zhao Y.

Nano Lett. 2013 Dec 11;13(12):6228-32. doi: 10.1021/nl4036687. Epub 2013 Nov 26.

PMID:
24256449
[PubMed - in process]
8.

G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.

Whittier KL, Boese EA, Gibson-Corley KN, Kirby PA, Darbro BW, Qian Q, Ingram WJ, Robertson T, Remke M, Taylor MD, O'Dorisio MS.

Acta Neuropathol Commun. 2013 Oct 10;1(1):66. doi: 10.1186/2051-5960-1-66.

PMID:
24252460
[PubMed]
Free PMC Article
9.

ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma.

Ingram WJ, Crowther LM, Little EB, Freeman R, Harliwong I, Veleva D, Hassall TE, Remke M, Taylor MD, Hallahan AR.

Exp Hematol Oncol. 2013 Oct 4;2(1):26. doi: 10.1186/2162-3619-2-26.

PMID:
24219920
[PubMed]
Free PMC Article
10.

Mice infected with low-virulence strains of Toxoplasma gondii lose their innate aversion to cat urine, even after extensive parasite clearance.

Ingram WM, Goodrich LM, Robey EA, Eisen MB.

PLoS One. 2013 Sep 18;8(9):e75246. doi: 10.1371/journal.pone.0075246. eCollection 2013.

PMID:
24058668
[PubMed - in process]
Free PMC Article
11.

Myeloma presenting during pregnancy.

Smith D, Stevens J, Quinn J, Cavenagh J, Ingram W, Yong K.

Hematol Oncol. 2014 Mar;32(1):52-5. doi: 10.1002/hon.2088. Epub 2013 Sep 1. No abstract available.

PMID:
23996410
[PubMed - indexed for MEDLINE]
12.

A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT).

Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A, Ingram W, Pinkney J, Ukoumunne OC, Vaidya B, Vickery J, Britten N.

BMJ Open. 2013 Jul 31;3(7). pii: e003396. doi: 10.1136/bmjopen-2013-003396.

PMID:
23903815
[PubMed]
Free PMC Article
13.

An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.

Hardwick N, Buchan S, Ingram W, Khan G, Vittes G, Rice J, Pulford K, Mufti G, Stevenson F, Guinn BA.

Cancer Immun. 2013 Jul 15;13:16. Print 2013.

PMID:
23882161
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.

Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, Ricigliano VA, Vittori D, Fornasiero A, Buscarinu MC; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium,2, Romano S, Salvetti M, Ristori G.

PLoS One. 2013 May 16;8(5):e63300. doi: 10.1371/journal.pone.0063300. Print 2013.

PMID:
23696811
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.

Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2013 Sep;120(9):1860-70. doi: 10.1016/j.ophtha.2013.01.073. Epub 2013 May 1.

PMID:
23642377
[PubMed - indexed for MEDLINE]
16.

Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).

Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group.

Invest Ophthalmol Vis Sci. 2013 Jul 8;54(7):4548-54. doi: 10.1167/iovs.13-11804.

PMID:
23620429
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures.

Freeman J, Walters R, Ingram W, Slade A, Hobart J, Zajicek J.

Mult Scler. 2013 Oct;19(12):1632-9. doi: 10.1177/1352458513482373. Epub 2013 Mar 25.

PMID:
23530002
[PubMed - indexed for MEDLINE]
18.

Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).

Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF; Comparison of AMD Treatments Trials Research Group.

Ophthalmology. 2013 Mar;120(3):593-9. doi: 10.1016/j.ophtha.2012.11.037. Epub 2013 Jan 18.

PMID:
23337555
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.

Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2013 Jan;120(1):122-9. doi: 10.1016/j.ophtha.2012.07.042. Epub 2012 Oct 6.

PMID:
23047002
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma.

Keating J, Tsoli M, Hallahan AR, Ingram WJ, Haber M, Ziegler DS.

Mol Cancer Ther. 2012 Dec;11(12):2654-63. doi: 10.1158/1535-7163.MCT-12-0352. Epub 2012 Sep 25.

PMID:
23012247
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk